The ATP13A2 gene helps the cell’s recycling centers work properly, especially in brain cells. This gene plays an important role in moving certain substances across these compartments so cells can clear waste and stay healthy. When the ATP13A2 gene does not work well, waste material can build up, and some people develop a rare inherited condition linked to early movement problems, stiffness, balance trouble, and changes in thinking or behavior. Symptoms and severity can vary from person to person.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes give the directions for producing proteins, the parts of cells that do much of the work. Others mainly help determine when a process happens, where it happens, and how active it is. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. If you want to go deeper into this topic, you can find more in the LearnHub.
Overview
ATP13A2Gene function
What if the gene works
The ATP13A2 gene helps lysosomes, your cells’ recycling centers, work properly. Its protein moves certain charged molecules across lysosome membranes, which supports waste breakdown and cell balance, especially in nerve cells.
Risk
What if the gene does not work
Variants in the ATP13A2 gene can cause movement and brain conditions, including early onset parkinsonism, and in some people learning, behavior, vision, or balance problems. Milder and more severe variants can influence when symptoms begin and which features appear.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the ATP13A2 gene is currently established. Care is based on symptoms, and medicines such as levodopa may help some people with ATP13A2 related parkinsonism, but this is not a gene specific rule. The ATP13A2 gene is also being studied in early stage research as a possible treatment target and biomarker in Parkinson disease and related brain conditions.
Conditions associated with ATP13A2
Gene function
What if the gene works
Inside many cells, the ATP13A2 gene supports tiny recycling compartments that clear used materials and keep cell contents balanced. Its protein sits mainly in lysosomes, where it helps manage certain small molecules called polyamines. This steady housekeeping is especially important in cells such as nerve cells, which need reliable cleanup over many years.
The ATP13A2 gene helps lysosomes, the cell's recycling centers, carry out routine cleanup. This lets used proteins and other cell material be broken down and reused in a controlled way.
Inside lysosomes, ATP13A2 helps move polyamines, small molecules that support normal cell activity. Keeping these molecules balanced is a key part of what the ATP13A2 gene does in cells each day.
By supporting healthy lysosomes, ATP13A2 helps autophagy (the process cells use to remove worn out parts) keep moving. This helps cells refresh older components as part of normal maintenance.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ATP13A2 gene can make its protein unstable, misfolded, or unable to reach lysosomes, which lowers transport activity and disrupts the cell’s waste handling. Some changes leave partial function, while more severe variants, including protein truncating changes, may lead to little or no activity. This connection between ATP13A2 gene variants and lysosome function helps explain why some people have earlier onset or more pronounced ATP13A2-related neurologic symptoms.
How variants are linked to conditions
Pathogenic variants in the ATP13A2 gene cause Kufor-Rakeb syndrome, a rare inherited form of young-onset Parkinson disease. People with this diagnosis often develop movement symptoms in childhood or early adulthood, such as stiffness, slowed movement, balance problems, and sometimes changes in learning or thinking. Some variants in the ATP13A2 gene have also been linked to other rare neurologic conditions, including certain forms of hereditary spastic paraplegia.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are commonly found in the general population. Most do not have a direct effect on health and instead reflect natural human variation. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors also play a part. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For ATP13A2-related conditions, risk is mainly shaped by inheritance. A child is at highest risk when both parents carry a harmful change in the ATP13A2 gene, and risk can be higher in families where blood relatives have children together. There is not enough evidence to say that diet, exercise, or other lifestyle changes lower this inherited risk.
Inheritance of ATP13A2 variants
ATP13A2-related conditions are inherited in an autosomal recessive pattern. This means a person usually develops an ATP13A2-related condition only when both copies of the ATP13A2 gene carry a disease-causing variant, with one altered copy inherited from each parent. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is a carrier, and a 25% chance of having a child with two non-affected copies. This is the established answer to how ATP13A2 variants are inherited in families.
What does my ATP13A2 result mean for my family?
For ATP13A2, family members are most often affected in a recessive pattern, which usually means parents may be healthy carriers and brothers or sisters could also be carriers or, less often, have the condition. Close relatives may want to learn whether the same gene change runs in the family, especially if there are similar movement, balance, or learning problems. The meaning for relatives depends on the exact ATP13A2 result and the condition linked to it.
Genetic information
Genetic testing
How you find out about variants
ATP13A2 genetic testing usually uses a blood or saliva sample to read your DNA and look for changes in the ATP13A2 gene. Results may identify a disease-causing variant, show that no relevant variant was found, or report a variant of uncertain significance, which means the finding is not yet clear.
When should I consider getting a genetic test?
Genetic testing for the ATP13A2 gene may be worth considering if someone has Parkinson-like movement problems starting in childhood or early adulthood, especially with stiffness, trouble walking, or learning and behavior changes. It can also help when these problems run in the family or affect brothers or sisters.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it shows depends on the condition and the type of variant involved. Lifestyle, environment, age, and medical history are among the many factors that shape how the body works over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it into tissues, or responds to its effects. This is a common reason why the same treatment may help one person more than another, or why some people are more likely to notice side effects at usual doses.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences affect the way people respond to medications. It looks at relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can help support treatment decisions that are more informed and more individualized. To explore this topic in greater detail, you can learn more in LearnHub.
Drugs influenced by the ATP13A2 gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding medication choice or dose at this time. If you have concerns about side effects, a new medicine, or how treatment fits with your overall health, talk with your doctor or pharmacist.
History
The ATP13A2 gene entered medical genetics through research on families with a rare inherited form of early onset parkinsonism called Kufor Rakeb syndrome. In 2006, researchers linked this condition to variants in the ATP13A2 gene, which marked an important step in understanding why some people develop Parkinson like symptoms at a young age. From these first observations, research expanded steadily. Scientists then connected the gene to a broader group of movement and nerve related conditions, which widened interest in its clinical role. Although it has not become a household name, the ATP13A2 gene remains an important part of the history of inherited parkinsonism research.